James He is a scientist and the founder of ForDoz Pharma Co. He has particular expertise in complex injectable product R&D, scale-up, and commercialization. Prior to founding ForDoz, James was the President and CEO of Changzhou Jinyuan Pharmaceuticals complex injectable business in China, which was successfully sold to a large pharma company after the launch of their first commercial doxorubicin liposome injectable product. Before that, James worked at Baxter Healthcare Corp. R&D group for 11 years. James holds an MS degree in chemistry from Tennessee Technological Univ.
.svg)
